More than 80% achieved at least 15% weight loss, supporting ongoing investigation in pharmacologic obesity management
Regardless of whether consumers use GLP-1s, stop using them, or choose not to use them at all, good nutrition principles remain central to sustainable weight management
Clinicians can use this as an opportunity to explain, in understandable terms, how GLP1s control appetite and cravings, and to guide patients toward long-term success through behavioral and nutritional support
Data were collected July 8 - August 8, 2024 in Japan (n=4502), and September 5 - October 14, 2024 in China (n=4519)
The Frontrunners (Orforglipron
But heres what its important to know: semaglutide amplifies a pathway